Discussion: GM-CSF plus rituximab results in high response rates, along with a tolerable safety profile in patients with relapsed or progressive FL.

• 讨论：复发性滤泡性淋巴瘤患者GM-CSF加美罗华治疗反应率高，有相当的安全性。